ImmunoGen Message Board - Msg: 28918656

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen

IMGN 31.23

0.0%

Feb 26 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rjk01 who wrote (5531)	5/28/2013 12:26:15 AM
From: Gary Mohilner	of 5665

ASCO will have several presentations by IMGN and it's partners on drugs which all appear to be in line to advance in trials. Of course their are several presentations on T-DM1 as well. Roche announced quarterly results of $19 million in sales last quarter on just a couple weeks of sales shortly after the quarter ended. I don't know is we can expect such an update in July, but suspect if we get it, it should be in the hundreds of millions, and that should get investors excited. The royalty payment to IMGN wouldn't be made during this quarter, so unless IMGN is free to disclose how much it's expecting, the quarterly may not sound that great, but each quarter should get better. I believe it won't take long before T-DM1 is selling billions annually, at that point even at the low royalty rate, I expect investors to be excited about the stock. Of course by that time I expect well over 90% will be in institutional hands which also should drive the price up as few shares will be open to most of us. Don't be surprised if we see $20 this week. Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next